"Depatuxizumab-mafodotin in EGFR-amplified newly diagnosed glioblastoma" by Minesh Mehta

Skip to main content

All Publications

Authors

Minesh Mehta, Miami Cancer InstituteFollow

Title

Depatuxizumab-mafodotin in EGFR-amplified newly diagnosed glioblastoma: a phase III randomized clinical trial

Publication Date

2-14-2023

Content Type

Article

PubMed ID:

Additional Authors:

Additional authors and institutional affiliations

Citation

Neuro-Oncology (2022) 25(2):339–350

This document is currently not available here.

Find in your library

COinS